Google Testing Pharmaceutical Ads in AI Mode and AI Overviews

Google has begun testing standard text and Shopping ads for certain pharmaceutical products, including prescription drugs, inside its AI Mode and AI Overviews surfaces in the United States. The expansion broadens what advertisers in regulated drug categories can run on Google’s generative search placements, with ads appearing in clearly labeled Sponsored sections.

What changed

A Google spokesperson told Adweek that Google “recently expanded to include certain pharmaceutical products” in its ongoing test of ads within AI Mode and AI Overviews. Google also shared a written statement: “We’re testing standard text and Shopping ads in AI Mode and AI Overviews, which we recently expanded to include certain pharmaceutical products.”

According to the same report, the testing for pharmaceutical products, including prescription drugs, began in October 2026 and is limited to the U.S. Pharmaceutical advertisers can run standard text and Shopping ads through existing campaign types, and the ads are placed in sections labeled as Sponsored so users can tell them apart from the AI-generated answers above.

Why it matters for advertisers

Until now, Google’s ads inside AI Mode and AI Overviews have skewed toward retail and consumer categories where Shopping feeds and text ads already perform well. Adding pharmaceutical products and prescription drugs brings a tightly regulated vertical into the AI search placements. For drugmakers, telehealth platforms, and online pharmacies that already advertise on Google Search and Shopping, AI Mode and AI Overviews are now a new surface where ad eligibility is expanding.

Because these ads sit directly under AI-generated answers, the placements give pharmaceutical brands a way to appear next to the very queries that trigger health-related AI summaries, such as questions about conditions, treatments, and medications. Standard Google Ads policies on pharmaceutical and healthcare advertising continue to apply, and only certified or approved advertisers in eligible categories can serve these ads.

Was there a policy update?

There does not appear to be a new written policy change. The previous updates that touched Google’s drug and pharmaceutical ads policies were issued in March 2026 and October 2025, with some regional changes in specific countries over the past year. Google has said the current expansion is part of the ongoing ad test in AI Mode and AI Overviews, not a new standalone policy.

This distinction matters for compliance teams. Marketers in this category should treat the change as a new placement inside an existing test rather than a fresh set of rules. Existing certifications, licensing checks, and Google Ads policies on pharmaceutical advertising remain the governing framework.

How the ads actually look

The ads take the same two forms already being tested inside AI Mode and AI Overviews:

• Standard text ads, which appear as the familiar blue-link units inside the Sponsored sections of an AI result.
• Shopping ads, which pull from a product feed and show an image, price, and merchant name in the same Sponsored area.

Both formats sit beneath the AI-generated answer, not inside the generated text itself, so users see a clear separation between the answer and the ad units.

What to watch next

Several signals will show whether this test becomes a permanent placement:

• Coverage: whether the test stays U.S.-only or expands to other markets where Google already runs drug ads.
• Inventory: which pharmaceutical subcategories, prescription versus over-the-counter, show up first.
• Pacing: how often Sponsored slots appear under health-related AI answers versus non-health queries.

Advertisers in the pharmaceutical space should expect a waiting period before they can run these placements and should rely on existing Google Ads certification and licensing requirements to qualify. Anyone managing healthcare ad accounts can monitor how a given site is being read by Google’s AI surfaces with an AI visibility audit, since changes in how ads and answers are paired often show up there first.

FAQ

Is Google now showing pharmaceutical ads in AI Mode and AI Overviews?

Google is testing standard text and Shopping ads for certain pharmaceutical products, including prescription drugs, inside AI Mode and AI Overviews. The test began in October 2026 and is currently limited to the U.S.

Did Google change its pharmaceutical ads policy for this?

No new written policy update has been announced. The most recent prior updates to Google’s drug and pharmaceutical ads policies were in March 2026 and October 2025. The current move is part of the ongoing ad test inside AI Mode and AI Overviews rather than a standalone policy change.

What do the pharmaceutical ads in AI Mode and AI Overviews look like?

They are standard text ads and Shopping ads placed in clearly labeled Sponsored sections beneath the AI-generated answer, using the same formats already being tested in those surfaces.

SEOScanPro

SEOScanPro runs a full technical audit of a site and shows the measured result behind every check. Open the AI visibility report.